{"filing": {"accession": "0001193125-26-076536", "cik": "0001395937", "ticker": "SNDX", "company_name": "Syndax Pharmaceuticals Inc", "form_type": "10-K", "filing_type": "10-K", "filing_date": "2026-02-26", "accepted_datetime": null, "acceptance_datetime": null, "accepted_at": null, "primary_doc_url": "https://www.sec.gov/Archives/edgar/data/1395937/000119312526076536/0001193125-26-076536-index.htm", "filing_url": "https://www.sec.gov/Archives/edgar/data/1395937/000119312526076536/0001193125-26-076536-index.htm", "period_of_report": "2025-12-31"}, "html_url": "/api/filings/000119312526076536/stream", "exhibits": [{"exhibit_number": "10.30", "exhibit_type": "10", "description": "Non-employee Director Compensation Policy, as amended, dated as of February 4, 2026.", "filename": "sndx-ex10_30.htm", "edgar_url": "https://www.sec.gov/Archives/edgar/data/1395937/000119312526076536/sndx-ex10_30.htm", "category": "contracts", "incorporated_by_reference": false}, {"exhibit_number": "19.1", "exhibit_type": "19", "description": "Insider Trading Policy.", "filename": "sndx-ex19_1.htm", "edgar_url": "https://www.sec.gov/Archives/edgar/data/1395937/000119312526076536/sndx-ex19_1.htm", "category": "other", "incorporated_by_reference": false}, {"exhibit_number": "21.1", "exhibit_type": "21", "description": "Subsidiaries of the Registrant.", "filename": "sndx-ex21_subsidiaries.htm", "edgar_url": "https://www.sec.gov/Archives/edgar/data/1395937/000119312526076536/sndx-ex21_subsidiaries.htm", "category": "other", "incorporated_by_reference": false}, {"exhibit_number": "23.1", "exhibit_type": "23", "description": "Consent of Independent Registered Public Accounting Firm.", "filename": "sndx-ex23_1.htm", "edgar_url": "https://www.sec.gov/Archives/edgar/data/1395937/000119312526076536/sndx-ex23_1.htm", "category": "other", "incorporated_by_reference": false}, {"exhibit_number": "24.1", "exhibit_type": "24", "description": "Power of Attorney (included on the signature page to this report).", "filename": "", "edgar_url": "https://www.sec.gov/Archives/edgar/data/1395937/000119312526076536/sndx-20251231.htm#power_attorney", "category": "other", "incorporated_by_reference": false}, {"exhibit_number": "31.1", "exhibit_type": "31", "description": "Certification of the Principal Executive Officer pursuant to Rule 13a-14(a) or 15d-14(a) of the Securities Exchange Act of 1934.", "filename": "sndx-ex31_1.htm", "edgar_url": "https://www.sec.gov/Archives/edgar/data/1395937/000119312526076536/sndx-ex31_1.htm", "category": "other", "incorporated_by_reference": false}, {"exhibit_number": "31.2", "exhibit_type": "31", "description": "Certification of the Principal Financial Officerand Principal Accounting Officer pursuant to Rule 13a-14(a) or 15d-14(a) of the Securities Exchange Act of 1934.", "filename": "sndx-ex31_2.htm", "edgar_url": "https://www.sec.gov/Archives/edgar/data/1395937/000119312526076536/sndx-ex31_2.htm", "category": "other", "incorporated_by_reference": false}, {"exhibit_number": "32.1", "exhibit_type": "32", "description": "Certification of Principal Executive Officer and Principal Financial Officer pursuant to Rule 13a-14(b) or 15d-14(b) of the Exchange Act and 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.", "filename": "sndx-ex32_1.htm", "edgar_url": "https://www.sec.gov/Archives/edgar/data/1395937/000119312526076536/sndx-ex32_1.htm", "category": "other", "incorporated_by_reference": false}, {"exhibit_number": "3.1", "exhibit_type": "3", "description": "Amended and Restated Certificate of Incorporation of the Company (incorporated herein by reference to Exhibit 3.1 to the Company\u2019s Current Report on Form 8-K (File No. 001-37708), as filed with the SEC on March 8, 2016).", "filename": "", "edgar_url": "https://www.sec.gov/Archives/edgar/data/1395937/000119312516496764/d119516dex31.htm", "category": "incorporation", "incorporated_by_reference": true}, {"exhibit_number": "3.2", "exhibit_type": "3", "description": "Certificate of Amendment to the Amended and Restated Certificate of Incorporation of the Company (incorporated herein by reference to Exhibit 3.1 to the Company\u2019s Current Report on Form 8-K (File No. 001-37708), as filed with the SEC on May 18, 2023).", "filename": "", "edgar_url": "https://www.sec.gov/Archives/edgar/data/1395937/000095017023022802/sndx-ex3_1.htm", "category": "incorporation", "incorporated_by_reference": true}, {"exhibit_number": "3.3", "exhibit_type": "3", "description": "Amended and Restated Bylaws of the Company (incorporated herein by reference to Exhibit 3.2 to the Company\u2019s Current Report on Form 8-K (File No. 001-37708), as filed with the SEC on March 8, 2016).", "filename": "", "edgar_url": "https://www.sec.gov/Archives/edgar/data/1395937/000119312516496764/d119516dex32.htm", "category": "incorporation", "incorporated_by_reference": true}, {"exhibit_number": "4.1", "exhibit_type": "4", "description": "Specimen Common Stock Certificate of the Company (incorporated herein by reference to Exhibit 4.1 to the Company\u2019s Registration Statement on Form S-1/A (File No. 333-208861), as filed with the SEC on February 20, 2016).", "filename": "", "edgar_url": "https://www.sec.gov/Archives/edgar/data/1395937/000119312516457615/d117131dex41.htm", "category": "other", "incorporated_by_reference": true}, {"exhibit_number": "4.2", "exhibit_type": "4", "description": "Form of Pre-Funded Warrant issued pursuant to the securities purchase agreement between the Company and Certain Purchasers, dated December 16, 2021 (incorporated by reference to Exhibit 4.1 to the Company\u2019s Current Report on Form 8-K (File No. 001-37708), as filed with the SEC on December 17, 2021).", "filename": "", "edgar_url": "https://www.sec.gov/Archives/edgar/data/1395937/000119312521361105/d274870dex41.htm", "category": "debt", "incorporated_by_reference": true}, {"exhibit_number": "4.3", "exhibit_type": "4", "description": "Description of Capital Stock (incorporated herein by reference to Exhibit 4.3 to the Company\u2019s Annual Report on Form 10-K (File No. 001-37708), as filed with the SEC on March 3, 2025).", "filename": "", "edgar_url": "https://www.sec.gov/Archives/edgar/data/1395937/000095017025030394/sndx-ex4_3.htm", "category": "debt", "incorporated_by_reference": true}, {"exhibit_number": "10.1", "exhibit_type": "10", "description": "2007 Stock Plan (incorporated herein by reference to Exhibit 10.3 to the Company\u2019s Registration Statement on Form S-1 (File No. 333-208861), as filed with the SEC on January 4, 2016).", "filename": "", "edgar_url": "https://www.sec.gov/Archives/edgar/data/1395937/000119312516420122/d39288dex103.htm", "category": "contracts", "incorporated_by_reference": true}, {"exhibit_number": "10.2", "exhibit_type": "10", "description": "2007 Stock Plan Amendment, dated as of March 8, 2013 (incorporated herein by reference to Exhibit 10.4 to the Company\u2019s Registration Statement on Form S-1 (File No. 333-208861), as filed with the SEC on January 4, 2016).", "filename": "", "edgar_url": "https://www.sec.gov/Archives/edgar/data/1395937/000119312516420122/d39288dex104.htm", "category": "contracts", "incorporated_by_reference": true}, {"exhibit_number": "10.3", "exhibit_type": "10", "description": "2007 Stock Plan Amendment, dated as of July 10, 2013 (incorporated herein by reference to Exhibit 10.5 to the Company\u2019s Registration Statement on Form S-1 (File No. 333-208861), as filed with the SEC on January 4, 2016).", "filename": "", "edgar_url": "https://www.sec.gov/Archives/edgar/data/1395937/000119312516420122/d39288dex105.htm", "category": "contracts", "incorporated_by_reference": true}, {"exhibit_number": "10.4", "exhibit_type": "10", "description": "2007 Stock Plan Amendment, dated as of January 23, 2014 (incorporated herein by reference to Exhibit 10.6 to the Company\u2019s Registration Statement on Form S-1 (File No. 333-208861), as filed with the SEC on January 4, 2016).", "filename": "", "edgar_url": "https://www.sec.gov/Archives/edgar/data/1395937/000119312516420122/d39288dex106.htm", "category": "contracts", "incorporated_by_reference": true}, {"exhibit_number": "10.5", "exhibit_type": "10", "description": "2007 Stock Plan Amendment, dated as of December 17, 2014 (incorporated herein by reference to Exhibit 10.7 to the Company\u2019s Registration Statement on Form S-1 (File No. 333-208861), as filed with the SEC on January 4, 2016).", "filename": "", "edgar_url": "https://www.sec.gov/Archives/edgar/data/1395937/000119312516420122/d39288dex107.htm", "category": "contracts", "incorporated_by_reference": true}, {"exhibit_number": "10.6", "exhibit_type": "10", "description": "2007 Stock Plan Amendment, dated as of May 28, 2015 (incorporated herein by reference to Exhibit 10.8 to the Company\u2019s Registration Statement on Form S-1 (File No. 333-208861), as filed with the SEC on January 4, 2016).", "filename": "", "edgar_url": "https://www.sec.gov/Archives/edgar/data/1395937/000119312516420122/d39288dex108.htm", "category": "contracts", "incorporated_by_reference": true}, {"exhibit_number": "10.7", "exhibit_type": "10", "description": "2007 Stock Plan Amendment, dated as of August 20, 2015 (incorporated herein by reference to Exhibit 10.9 to the Company\u2019s Registration Statement on Form S-1 (File No. 333-208861), as filed with the SEC on January 4, 2016).", "filename": "", "edgar_url": "https://www.sec.gov/Archives/edgar/data/1395937/000119312516420122/d39288dex109.htm", "category": "contracts", "incorporated_by_reference": true}, {"exhibit_number": "10.8", "exhibit_type": "10", "description": "Form of Incentive Stock Option Agreement under 2007 Stock Plan (incorporated herein by reference to Exhibit 10.10 to the Company\u2019s Registration Statement on Form S-1 (File No. 333-208861), as filed with the SEC on January 4, 2016).", "filename": "", "edgar_url": "https://www.sec.gov/Archives/edgar/data/1395937/000119312516420122/d39288dex1010.htm", "category": "contracts", "incorporated_by_reference": true}, {"exhibit_number": "10.9", "exhibit_type": "10", "description": "Form of Non-Statutory Stock Option Agreement under 2007 Stock Plan (incorporated herein by reference to Exhibit 10.11 to the Company\u2019s Registration Statement on Form S-1 (File No. 333-208861), as filed with the SEC on January 4, 2016).", "filename": "", "edgar_url": "https://www.sec.gov/Archives/edgar/data/1395937/000119312516420122/d39288dex1011.htm", "category": "contracts", "incorporated_by_reference": true}, {"exhibit_number": "10.10", "exhibit_type": "10", "description": "2015 Omnibus Incentive Plan (incorporated herein by reference to Exhibit 10.12 to the Company\u2019s Registration Statement on Form S-8 (File No. 333-210412), as filed with the SEC on March 25, 2016).", "filename": "", "edgar_url": "https://www.sec.gov/Archives/edgar/data/1395937/000119312516420122/d39288dex1012.htm", "category": "contracts", "incorporated_by_reference": true}, {"exhibit_number": "10.11", "exhibit_type": "10", "description": "Form of Incentive Stock Option Agreement under 2015 Omnibus Incentive Plan (incorporated herein by reference to Exhibit 4.13 to the Company\u2019s Registration Statement on Form S-8 (File No. 333-210412), as filed with the SEC on January 4, 2016).", "filename": "", "edgar_url": "https://www.sec.gov/Archives/edgar/data/1395937/000119312516420122/d39288dex1013.htm", "category": "contracts", "incorporated_by_reference": true}, {"exhibit_number": "10.12", "exhibit_type": "10", "description": "Form of Non-Qualified Option Agreement under 2015 Omnibus Incentive Plan (incorporated herein by reference to Exhibit 10.14 to the Company\u2019s Registration Statement on Form S-1 (File No. 333-208861), as filed with the SEC on March 25, 2016).", "filename": "", "edgar_url": "https://www.sec.gov/Archives/edgar/data/1395937/000119312516420122/d39288dex1014.htm", "category": "contracts", "incorporated_by_reference": true}, {"exhibit_number": "10.13", "exhibit_type": "10", "description": "Form of Stock Unit Agreement under 2015 Omnibus Incentive Plan (incorporated herein by reference to Exhibit 10.1 to the Company\u2019s Quarterly Report on Form 10-Q (File No. 001-37708), as filed with the SEC on August 6, 2020).", "filename": "", "edgar_url": "https://www.sec.gov/Archives/edgar/data/1395937/000156459020037777/sndx-ex101_313.htm", "category": "contracts", "incorporated_by_reference": true}, {"exhibit_number": "10.14", "exhibit_type": "10", "description": "Form of Deferred Settlement Stock Unit Agreement under 2015 Omnibus Incentive Plan (incorporated herein by reference to Exhibit 10.14 to the Company\u2019s Annual Report on Form 10-K (file No. 001-37708), as filed with the SEC on March 12, 2021).", "filename": "", "edgar_url": "https://www.sec.gov/Archives/edgar/data/1395937/000156459021012607/sndx-ex1014_191.htm", "category": "contracts", "incorporated_by_reference": true}, {"exhibit_number": "10.15", "exhibit_type": "10", "description": "2015 Employee Stock Purchase Plan (incorporated herein by reference to Exhibit 4.16 to the Company\u2019s Registration Statement on Form S-8 (File No. 333-210412), as filed with the SEC on March 25, 2016).", "filename": "", "edgar_url": "https://www.sec.gov/Archives/edgar/data/1395937/000119312516518181/d166957dex416.htm", "category": "contracts", "incorporated_by_reference": true}, {"exhibit_number": "10.16", "exhibit_type": "10", "description": "Syndax Pharmaceuticals, Inc. 2023 Inducement Plan, as amended (incorporated herein by reference to Exhibit 10.16 to the Company\u2019s Annual Report on Form 10-K (filed No. 001-37708), as filed with the SEC on March 3, 2025).", "filename": "", "edgar_url": "https://www.sec.gov/Archives/edgar/data/1395937/000095017025030394/sndx-ex10_16.htm", "category": "contracts", "incorporated_by_reference": true}, {"exhibit_number": "10.17", "exhibit_type": "10", "description": "Form of Option Agreement pursuant to the Syndax Pharmaceuticals, Inc. 2023 Inducement Plan (incorporated herein by reference to Exhibit 10.2 to the Company\u2019s Current Report on Form 8-K (File No. 001-37708), as filed with the SEC on February 8, 2023).", "filename": "", "edgar_url": "https://www.sec.gov/Archives/edgar/data/1395937/000095017023002172/sndx-ex10_2.htm", "category": "contracts", "incorporated_by_reference": true}, {"exhibit_number": "10.18", "exhibit_type": "10", "description": "Form of Restricted Stock Unit Agreement pursuant to the Syndax Pharmaceuticals, Inc. 2023 Inducement Plan (incorporated herein by reference to Exhibit 10.2 to the Company\u2019s Quarterly Report on Form 10-Q (File No. 001-37708), as filed with the SEC on May 8, 2023).", "filename": "", "edgar_url": "https://www.sec.gov/Archives/edgar/data/1395937/000095017023018806/sndx-ex10_2.htm", "category": "contracts", "incorporated_by_reference": true}, {"exhibit_number": "10.19", "exhibit_type": "10", "description": "Amended and Restated Executive Employment Agreement by and between the Company and Michael A. Metzger, dated as of February 2, 2022 (incorporated herein by reference to Exhibit 10.17 to the Company's Annual Report on Form 10-K (File No. 001-37708), as filed with the SEC on March 1, 2022).", "filename": "", "edgar_url": "https://www.sec.gov/Archives/edgar/data/1395937/000156459022008112/sndx-ex1017_443.htm", "category": "contracts", "incorporated_by_reference": true}, {"exhibit_number": "10.20", "exhibit_type": "10", "description": "Amendment to Amended and Restated Executive Employment by and between the Company and Michael A. Metzger, dated as of February 26, 2024 (incorporated herein by reference to Exhibit 10.20 to the Company's Annual Report on Form 10-K (File No. 001-37708), as filed with the SEC on February 27, 2024).", "filename": "", "edgar_url": "https://www.sec.gov/Archives/edgar/data/1395937/000095017024021253/sndx-ex10_20.htm", "category": "contracts", "incorporated_by_reference": true}, {"exhibit_number": "10.21", "exhibit_type": "10", "description": "Amended and Restated Executive Employment Agreement by and between the Company and Luke J. Albrecht, dated as of April 27, 2020 (incorporated herein by reference to Exhibit 10.22 to the Company's Annual Report on Form 10-K (File No. 001-37708), as filed with the SEC on February 27, 2024).", "filename": "", "edgar_url": "https://www.sec.gov/Archives/edgar/data/1395937/000095017024021253/sndx-ex10_22.htm", "category": "contracts", "incorporated_by_reference": true}, {"exhibit_number": "10.22", "exhibit_type": "10", "description": "Amendment to Amended and Restated Executive Employment by and between the Company and Luke J. Albrecht, dated as of February 26, 2024 (incorporated herein by reference to Exhibit 10.23 to the Company's Annual Report on Form 10-K (File No. 001-37708), as filed with the SEC on February 27, 2024).", "filename": "", "edgar_url": "https://www.sec.gov/Archives/edgar/data/1395937/000095017024021253/sndx-ex10_23.htm", "category": "contracts", "incorporated_by_reference": true}, {"exhibit_number": "10.23", "exhibit_type": "10", "description": "Executive Employment Agreement by and between the Company and Keith A. Goldan, dated as of June 8, 2022 (incorporated herein by reference to Exhibit 10.1 to the Company\u2019s Current Report on Form 8-K (File No. 001-37708), as filed with the SEC on June 13, 2022).", "filename": "", "edgar_url": "https://www.sec.gov/Archives/edgar/data/1395937/000156459022023045/sndx-ex101_16.htm", "category": "contracts", "incorporated_by_reference": true}, {"exhibit_number": "10.24", "exhibit_type": "10", "description": "Amendment to Executive Employment by and between the Company and Keith A. Goldan, dated as of February 26, 2024 (incorporated herein by reference to Exhibit 10.27 to the Company's Annual Report on Form 10-K (File No. 001-37708), as filed with the SEC on February 27, 2024).", "filename": "", "edgar_url": "https://www.sec.gov/Archives/edgar/data/1395937/000095017024021253/sndx-ex10_27.htm", "category": "contracts", "incorporated_by_reference": true}, {"exhibit_number": "10.25", "exhibit_type": "10", "description": "Executive Employment Agreement by and between the Company and Neil Gallagher, M.D., Ph.D., dated as of March 30, 2023 (incorporated herein by reference to Exhibit 10.1 to the Company\u2019s Current Report on Form 8-K (File No. 001-37708), as filed with the SEC on March 30, 2023).", "filename": "", "edgar_url": "https://www.sec.gov/Archives/edgar/data/1395937/000095017023010756/sndx-ex10_1.htm", "category": "contracts", "incorporated_by_reference": true}, {"exhibit_number": "10.26", "exhibit_type": "10", "description": "Amendment to Executive Employment by and between the Company and Neil Gallagher, M.D., Ph.D., dated as of February 26, 2024 (incorporated herein by reference to Exhibit 10.30 to the Company's Annual Report on Form 10-K (File No. 001-37708), as filed with the SEC on February 27, 2024).", "filename": "", "edgar_url": "https://www.sec.gov/Archives/edgar/data/1395937/000095017024021253/sndx-ex10_30.htm", "category": "contracts", "incorporated_by_reference": true}, {"exhibit_number": "10.27", "exhibit_type": "10", "description": "Executive Employment Agreement by and between the Company and Steven Closter, dated as of March 18, 2024 (incorporated herein by reference to Exhibit 10.1 to the Company\u2019s Current Report on Form 8-K (File No. 001-37708), as filed with the SEC on March 18, 2024).", "filename": "", "edgar_url": "https://www.sec.gov/Archives/edgar/data/1395937/000095017024032514/sndx-ex10_1.htm", "category": "contracts", "incorporated_by_reference": true}, {"exhibit_number": "10.28", "exhibit_type": "10", "description": "Executive Employment Agreement, dated May 12, 2025, by and between the Company and Dr. Nicholas Botwood (incorporated herein by reference to Exhibit 10.1 to the Company\u2019s Current Report on Form 8-K (File No. 001-37708, as filed with the SEC on May 16, 2025).", "filename": "", "edgar_url": "https://www.sec.gov/Archives/edgar/data/1395937/000095017025073555/sndx-ex10_1.htm", "category": "contracts", "incorporated_by_reference": true}, {"exhibit_number": "10.29", "exhibit_type": "10", "description": "Non-employee Director Compensation Policy, as amended, dated as of February 5, 2025 (incorporated herein by reference to Exhibit 10.28 to the Company's Annual Report on Form 10-K (File No. 001-37708), as filed with the SEC on March 3, 2025).", "filename": "", "edgar_url": "https://www.sec.gov/Archives/edgar/data/1395937/000095017025030394/sndx-ex10_28.htm", "category": "contracts", "incorporated_by_reference": true}, {"exhibit_number": "10.31", "exhibit_type": "10", "description": "Form of Indemnification Agreement by and between the company and each of its directors and officers (incorporated herein by reference to Exhibit 10.21 to the Company\u2019s Registration Statement on Form S-1 (File No. 333-208861), as filed with the SEC on January 4, 2016).", "filename": "", "edgar_url": "https://www.sec.gov/Archives/edgar/data/1395937/000119312516420122/d39288dex1021.htm", "category": "contracts", "incorporated_by_reference": true}, {"exhibit_number": "10.34", "exhibit_type": "10", "description": "Second Amendment to the License, Development and Commercialization Agreement by and between the company and Bayer Pharma AG, dated as of February 1, 2013 (incorporated herein by reference to Exhibit 10.24 to the Company\u2019s Registration Statement on Form S-1 (File No. 333-208861), as filed with the SEC on January 4, 2016).", "filename": "", "edgar_url": "https://www.sec.gov/Archives/edgar/data/1395937/000119312516420122/d39288dex1024.htm", "category": "contracts", "incorporated_by_reference": true}, {"exhibit_number": "10.44", "exhibit_type": "10", "description": "Purchase Agreement by and between the Company and Incyte Corporation, dated as of September 24, 2021 (incorporated herein by reference to Exhibit 10.2 to the Company\u2019s Quarterly Report on Form 10-Q (File No. 001-37708), as filed with the SEC on November 15, 2021).", "filename": "", "edgar_url": "https://www.sec.gov/Archives/edgar/data/1395937/000156459021057004/sndx-ex102_181.htm", "category": "contracts", "incorporated_by_reference": true}, {"exhibit_number": "97", "exhibit_type": "97", "description": "Incentive Compensation Recoupment Policy (incorporated herein by reference to Exhibit 97 to the Company's Annual Report on Form 10-K (File No. 001-37708), as filed with the SEC on March 3, 2025).", "filename": "", "edgar_url": "https://www.sec.gov/Archives/edgar/data/1395937/000095017024021253/sndx-ex97.htm", "category": "other", "incorporated_by_reference": true}], "sections": [{"section_name": "item_1", "section_title": "Business", "start_position": 4970, "end_position": 4991}, {"section_name": "item_1a", "section_title": "Risk Factors", "start_position": 4991, "end_position": 5018}, {"section_name": "item_1b", "section_title": "Unresolved Staff Comments", "start_position": 5018, "end_position": 5058}, {"section_name": "item_1c", "section_title": "Cybersecurity", "start_position": 5058, "end_position": 5086}, {"section_name": "item_2", "section_title": "Properties", "start_position": 5086, "end_position": 5110}, {"section_name": "item_3", "section_title": "Legal Proceedings", "start_position": 5110, "end_position": 5141}, {"section_name": "item_4", "section_title": "Mine Safety Disclosures", "start_position": 5141, "end_position": 5183}, {"section_name": "item_5", "section_title": "Market for Registrant's Common Equity", "start_position": 5194, "end_position": 5341}, {"section_name": "item_7", "section_title": "Management's Discussion and Analysis", "start_position": 5341, "end_position": 5440}, {"section_name": "item_7a", "section_title": "Quantitative and Qualitative Disclosures", "start_position": 5440, "end_position": 5513}, {"section_name": "item_8", "section_title": "Financial Statements", "start_position": 5513, "end_position": 5668}, {"section_name": "item_9a", "section_title": "Controls and Procedures", "start_position": 5668, "end_position": 5706}, {"section_name": "item_9b", "section_title": "Other Information", "start_position": 5706, "end_position": 5837}, {"section_name": "item_10", "section_title": "Directors and Executive Officers", "start_position": 5837, "end_position": 5906}, {"section_name": "item_11", "section_title": "Executive Compensation", "start_position": 5906, "end_position": 5943}, {"section_name": "item_12", "section_title": "Security Ownership", "start_position": 5943, "end_position": 6052}, {"section_name": "item_13", "section_title": "Certain Relationships", "start_position": 6052, "end_position": 6140}, {"section_name": "item_14", "section_title": "Principal Accountant Fees", "start_position": 6140, "end_position": 6198}, {"section_name": "item_16", "section_title": "Form 10-K Summary", "start_position": 6265, "end_position": 347217}, {"section_name": "item_15", "section_title": "Exhibits and Financial Statement Schedules", "start_position": 347217, "end_position": 477897}], "tables": [{"table_index": 0, "table_type": "text", "caption": null, "header_text": ""}, {"table_index": 1, "table_type": "text", "caption": null, "header_text": ""}, {"table_index": 2, "table_type": "text", "caption": null, "header_text": ""}, {"table_index": 3, "table_type": "text", "caption": null, "header_text": ""}, {"table_index": 4, "table_type": "exhibit_index", "caption": null, "header_text": ""}, {"table_index": 5, "table_type": "financial", "caption": null, "header_text": ""}, {"table_index": 6, "table_type": "financial", "caption": null, "header_text": ""}, {"table_index": 7, "table_type": "financial", "caption": null, "header_text": ""}, {"table_index": 8, "table_type": "text", "caption": null, "header_text": ""}, {"table_index": 9, "table_type": "text", "caption": null, "header_text": ""}, {"table_index": 10, "table_type": "financial", "caption": null, "header_text": ""}, {"table_index": 11, "table_type": "exhibit_index", "caption": null, "header_text": ""}, {"table_index": 12, "table_type": "exhibit_index", "caption": null, "header_text": ""}, {"table_index": 13, "table_type": "exhibit_index", "caption": null, "header_text": ""}, {"table_index": 14, "table_type": "exhibit_index", "caption": null, "header_text": ""}, {"table_index": 15, "table_type": "exhibit_index", "caption": null, "header_text": ""}, {"table_index": 16, "table_type": "text", "caption": null, "header_text": ""}, {"table_index": 17, "table_type": "text", "caption": null, "header_text": ""}, {"table_index": 18, "table_type": "financial", "caption": null, "header_text": ""}, {"table_index": 19, "table_type": "financial", "caption": null, "header_text": ""}, {"table_index": 20, "table_type": "financial", "caption": null, "header_text": ""}, {"table_index": 21, "table_type": "financial", "caption": null, "header_text": ""}, {"table_index": 22, "table_type": "financial", "caption": null, "header_text": ""}, {"table_index": 23, "table_type": "financial", "caption": null, "header_text": ""}, {"table_index": 24, "table_type": "text", "caption": null, "header_text": ""}, {"table_index": 25, "table_type": "financial", "caption": null, "header_text": ""}, {"table_index": 26, "table_type": "text", "caption": null, "header_text": ""}, {"table_index": 27, "table_type": "text", "caption": null, "header_text": ""}, {"table_index": 28, "table_type": "text", "caption": null, "header_text": ""}, {"table_index": 29, "table_type": "text", "caption": null, "header_text": ""}, {"table_index": 30, "table_type": "financial", "caption": null, "header_text": ""}, {"table_index": 31, "table_type": "text", "caption": null, "header_text": ""}, {"table_index": 32, "table_type": "financial", "caption": null, "header_text": ""}, {"table_index": 33, "table_type": "financial", "caption": null, "header_text": ""}, {"table_index": 34, "table_type": "text", "caption": null, "header_text": ""}, {"table_index": 35, "table_type": "text", "caption": null, "header_text": ""}, {"table_index": 36, "table_type": "text", "caption": null, "header_text": ""}, {"table_index": 37, "table_type": "text", "caption": null, "header_text": ""}, {"table_index": 38, "table_type": "text", "caption": null, "header_text": ""}, {"table_index": 39, "table_type": "text", "caption": null, "header_text": ""}, {"table_index": 40, "table_type": "financial", "caption": null, "header_text": ""}, {"table_index": 41, "table_type": "financial", "caption": null, "header_text": ""}, {"table_index": 42, "table_type": "financial", "caption": null, "header_text": ""}, {"table_index": 43, "table_type": "text", "caption": null, "header_text": ""}, {"table_index": 44, "table_type": "text", "caption": null, "header_text": ""}, {"table_index": 45, "table_type": "financial", "caption": null, "header_text": ""}], "exhibits_pending": false, "cdn_html": true, "response_time_ms": 39}